Cara Therapeutics Inc. (TVRD)
NASDAQ · Healthcare
Cara Therapeutics Inc. Operating Income 2012–2024
Cara Therapeutics Inc. annual/quarterly operating income history and growth rate from 2012 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cara Therapeutics Inc. operating income for the quarter ending March 31, 2025 was -4.4 M, a 85.32% decrease year-over-year.
- Cara Therapeutics Inc. operating income for the twelve months ending March 31, 2025 was -46.9 M, a 58.42% decrease year-over-year.
- Cara Therapeutics Inc. annual operating income for 2024 was -28.1 M, a 76.87% decrease from 2023.
- Cara Therapeutics Inc. annual operating income for 2023 was -121.5 M, a 38.80% increase from 2022.
- Cara Therapeutics Inc. annual operating income for 2022 was -87.5 M, a 1.74% decrease from 2021.
- Cara Therapeutics Inc. annual operating income for 2021 was -89.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cara Therapeutics Inc. Operating Income — FAQ
Cara Therapeutics Inc. (TVRD) operating income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is Cara Therapeutics Inc.'s operating income?
Cara Therapeutics Inc. (TVRD) reported operating income of -$28M for fiscal 2024.
Where can I see TVRD's operating income history?
The chart and table above show Cara Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.